174 related articles for article (PubMed ID: 12015242)
1. Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among medicare beneficiaries.
Weiss JP; Saynina O; McDonald KM; McClellan MB; Hlatky MA
Am J Med; 2002 May; 112(7):519-27. PubMed ID: 12015242
[TBL] [Abstract][Full Text] [Related]
2. Impact of the implantable cardioverter-defibrillator on rehospitalizations.
Valenti R; Schlåpfer J; Fromer M; Fischer A; Kappenberger L
Eur Heart J; 1996 Oct; 17(10):1565-71. PubMed ID: 8909915
[TBL] [Abstract][Full Text] [Related]
3. Trends in hospital treatment of ventricular arrhythmias among Medicare beneficiaries, 1985 to 1995.
McDonald KM; Hlatky MA; Saynina O; Geppert J; Garber AM; McClellan MB
Am Heart J; 2002 Sep; 144(3):413-21. PubMed ID: 12228777
[TBL] [Abstract][Full Text] [Related]
4. Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator: the Canadian implantable defibrillator study.
Sheldon R; O'Brien BJ; Blackhouse G; Goeree R; Mitchell B; Klein G; Roberts RS; Gent M; Connolly SJ
Circulation; 2001 Oct; 104(14):1622-6. PubMed ID: 11581139
[TBL] [Abstract][Full Text] [Related]
5. Mortality reduction by implantable cardioverter-defibrillators in high-risk patients with heart failure, ischemic heart disease, and new-onset ventricular arrhythmia: an effectiveness study.
Chan PS; Hayward RA
J Am Coll Cardiol; 2005 May; 45(9):1474-81. PubMed ID: 15862422
[TBL] [Abstract][Full Text] [Related]
6. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
N Engl J Med; 1997 Nov; 337(22):1576-83. PubMed ID: 9411221
[TBL] [Abstract][Full Text] [Related]
7. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS
Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of the implantable cardioverter-defibrillator: results from the Canadian Implantable Defibrillator Study (CIDS).
O'Brien BJ; Connolly SJ; Goeree R; Blackhouse G; Willan A; Yee R; Roberts RS; Gent M
Circulation; 2001 Mar; 103(10):1416-21. PubMed ID: 11245646
[TBL] [Abstract][Full Text] [Related]
9. Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator.
Owens DK; Sanders GD; Heidenreich PA; McDonald KM; Hlatky MA
Am Heart J; 2002 Sep; 144(3):440-8. PubMed ID: 12228780
[TBL] [Abstract][Full Text] [Related]
10. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
Bardy GH; Yee R; Jung W
J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
[TBL] [Abstract][Full Text] [Related]
11. Utilization and outcomes of the implantable cardioverter defibrillator, 1987 to 1995.
Hlatky MA; Saynina O; McDonald KM; Garber AM; McClellan MB
Am Heart J; 2002 Sep; 144(3):397-403. PubMed ID: 12228775
[TBL] [Abstract][Full Text] [Related]
12. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
[TBL] [Abstract][Full Text] [Related]
13. Food for afterthought: reflections from 2 implantable cardioverter defibrillator trials.
Rahimtoola SH
Arch Intern Med; 2004 Sep; 164(17):1835-9. PubMed ID: 15451756
[No Abstract] [Full Text] [Related]
14. Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors. A randomized study.
Wever EF; Hauer RN; Schrijvers G; van Capelle FJ; Tijssen JG; Crijns HJ; Algra A; Ramanna H; Bakker PF; Robles de Medina EO
Circulation; 1996 Feb; 93(3):489-96. PubMed ID: 8565166
[TBL] [Abstract][Full Text] [Related]
15. Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
Borne RT; Peterson PN; Greenlee R; Heidenreich PA; Wang Y; Curtis JP; Tzou WS; Varosy PD; Kremers MS; Masoudi FA
Circulation; 2014 Sep; 130(10):845-53. PubMed ID: 25095884
[TBL] [Abstract][Full Text] [Related]
16. Evidence rather than costs must guide use of the implantable cardioverter defibrillator.
Delacretaz E; Schlaepfer J; Metzger J; Fromer M; Kappenberger L
Am J Cardiol; 2000 Nov; 86(9A):52K-57K. PubMed ID: 11084101
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of the implantable cardioverter-defibrillator versus antiarrhythmic drugs in survivors of serious ventricular tachyarrhythmias: results of the Antiarrhythmics Versus Implantable Defibrillators (AVID) economic analysis substudy.
Larsen G; Hallstrom A; McAnulty J; Pinski S; Olarte A; Sullivan S; Brodsky M; Powell J; Marchant C; Jennings C; Akiyama T;
Circulation; 2002 Apr; 105(17):2049-57. PubMed ID: 11980684
[TBL] [Abstract][Full Text] [Related]
18. Implantable transvenous cardioverter-defibrillators.
Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
[TBL] [Abstract][Full Text] [Related]
19. Implantable cardioverter-defibrillator in the elderly: Predictors of appropriate interventions and mortality at 12-month follow-up.
Ferretto S; Zorzi A; Dalla Valle C; Migliore F; Leoni L; De Lazzari M; Corrado D; Iliceto S; Bertaglia E
Pacing Clin Electrophysiol; 2017 Dec; 40(12):1368-1373. PubMed ID: 28994461
[TBL] [Abstract][Full Text] [Related]
20. The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators.
Bhavnani SP; Kluger J; Coleman CI; White CM; Guertin D; Shafi NA; Yarlagadda RK; Clyne CA
Heart Rhythm; 2010 Jun; 7(6):755-60. PubMed ID: 20211275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
